Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose TSEBT Followed by Maintenance Valchlor for Mycosis Fungoides
NCT03288818Phase 2Withdrawn
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Aug 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mechlorethamine in mycosis fungoides (MF), sponsored by Sidney Kimmel Comprehensive Cancer Center. Planned start Aug 2018; status: withdrawn.
02
Drugs
mechlorethamine
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on NCT03288818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03288818.